Neuronetics, Inc. (STIM)
NASDAQ: STIM · Real-Time Price · USD
2.250
-0.130 (-5.46%)
At close: Oct 30, 2026, 4:00 PM EDT
2.288
+0.038 (1.69%)
After-hours: Oct 30, 2026, 7:44 PM EDT

Neuronetics Revenue

Neuronetics had revenue of $41.57M in the quarter ending June 30, 2026, with 9.08% growth. This brings the company's total for the last twelve months to $155.10M, up 39.59% year-over-year. In the year 2025, Neuronetics had annual revenue of $149.16M with 99.17% growth. That makes Neuronetics the 19,376th largest company in the world by revenue and 3,036th in the United States.

Revenue (ttm)
$155.10M
Revenue Growth
+39.59%
P/S Ratio
1.11
Revenue / Employee
$235,708
Employees
658
Market Cap
171.44M

Revenue Chart

Revenue by Segment

By Segment

Chart
  • Greenbrook 86.98M 58.3%
  • NeuroStar 62.18M 41.7%

By Geography

Chart
  • United States 146.05M 97.9%
  • International 3.11M 2.1%
Fiscal year ended Dec 31, 2025 See the full Neuronetics breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025149.16M74.27M99.17%
Dec 31, 202474.89M3.54M4.96%
Dec 31, 202371.35M6.14M9.42%
Dec 31, 202265.21M9.89M17.89%
Dec 31, 202155.31M6.07M12.32%
Dec 31, 202049.24M-13.41M-21.41%
Dec 31, 201962.66M9.88M18.72%
Dec 31, 201852.78M12.34M30.53%
Dec 31, 201740.43M6.21M18.13%
Dec 31, 201634.23M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Inogen354.30M
Quanterix153.41M
RxSight127.58M
Owlet114.41M
Pulmonx88.78M
Standard BioTools84.60M
Electromed73.78M
TriSalus Life Sciences45.08M
Revenue Rankings